Array
(
[1553492881] => Array
(
[wpm_update_stats] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => hourly
[args] => Array
(
)
[interval] => 3600
)
)
)
[1553494352] => Array
(
[wordfence_hourly_cron] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => hourly
[args] => Array
(
)
[interval] => 3600
)
)
)
[1553495973] => Array
(
[wp_privacy_delete_old_export_files] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => hourly
[args] => Array
(
)
[interval] => 3600
)
)
)
[1553496385] => Array
(
[wordfence_processAttackData] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] =>
[args] => Array
(
)
)
)
)
[1553503771] => Array
(
[wp_scheduled_auto_draft_delete] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
)
[1553508911] => Array
(
[delete_expired_transients] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
)
[1553508952] => Array
(
[wpseo-reindex-links] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
)
[1553515952] => Array
(
[wordfence_daily_cron] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
)
[1553520726] => Array
(
[wp_update_themes] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => twicedaily
[args] => Array
(
)
[interval] => 43200
)
)
[wp_version_check] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => twicedaily
[args] => Array
(
)
[interval] => 43200
)
)
[wp_update_plugins] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => twicedaily
[args] => Array
(
)
[interval] => 43200
)
)
)
[1553521474] => Array
(
[wp_scheduled_delete] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
)
[1553526000] => Array
(
[wordfence_email_activity_report] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] =>
[args] => Array
(
)
)
)
)
[1553527073] => Array
(
[wp_session_garbage_collection] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => twicedaily
[args] => Array
(
)
[interval] => 43200
)
)
)
[1553530024] => Array
(
[akismet_scheduled_delete] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
)
[1553533011] => Array
(
[yoast_tracking] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
)
[1553554832] => Array
(
[publish_future_post] => Array
(
[aa11aa901e9c7fa426bc76aa2905e5a4] => Array
(
[schedule] =>
[args] => Array
(
[0] => 427034
)
)
)
)
[1553641250] => Array
(
[publish_future_post] => Array
(
[1f3d24059f96d9e259518bca8d2c4d45] => Array
(
[schedule] =>
[args] => Array
(
[0] => 399265
)
)
)
)
[1553641252] => Array
(
[publish_future_post] => Array
(
[f424dbe879bbeb64820a496b9b964c34] => Array
(
[schedule] =>
[args] => Array
(
[0] => 425172
)
)
)
)
[1554069658] => Array
(
[publish_future_post] => Array
(
[30870f619857112e7f5a94a898b1f874] => Array
(
[schedule] =>
[args] => Array
(
[0] => 428209
)
)
)
)
[1554674448] => Array
(
[publish_future_post] => Array
(
[ff60c73b1e4862a319c959dd8a390668] => Array
(
[schedule] =>
[args] => Array
(
[0] => 426546
)
)
)
)
[1560808829] => Array
(
[publish_future_post] => Array
(
[b5d3dc26a5d6e8c9ef68ff7210d9c108] => Array
(
[schedule] =>
[args] => Array
(
[0] => 413991
)
)
)
)
[1572217239] => Array
(
[publish_future_post] => Array
(
[e2d49b23925e3371aea8db1c72521461] => Array
(
[schedule] =>
[args] => Array
(
[0] => 421241
)
)
)
)
[1580169600] => Array
(
[publish_future_post] => Array
(
[2d492587fa52e9c78f7043ddf937b0a1] => Array
(
[schedule] =>
[args] => Array
(
[0] => 18611
)
)
[dea3edad73162f380bc9dc44fa3407bf] => Array
(
[schedule] =>
[args] => Array
(
[0] => 19670
)
)
[2caa9c58a241c4f77a6856802c1b43fb] => Array
(
[schedule] =>
[args] => Array
(
[0] => 20734
)
)
[307b37ba29b8cd716eafa809661756e3] => Array
(
[schedule] =>
[args] => Array
(
[0] => 22852
)
)
[365be9eba8e62abb0c0d4bfe013a2687] => Array
(
[schedule] =>
[args] => Array
(
[0] => 23918
)
)
[0e942b20ffb9550322105263ad82126f] => Array
(
[schedule] =>
[args] => Array
(
[0] => 24977
)
)
[661c5eb39689fe2133ff7986ac6628fb] => Array
(
[schedule] =>
[args] => Array
(
[0] => 26036
)
)
[75562b264e355915e4dea97042a28f7e] => Array
(
[schedule] =>
[args] => Array
(
[0] => 27095
)
)
[11cf4e8a6f842b0115881551a29c47f6] => Array
(
[schedule] =>
[args] => Array
(
[0] => 28154
)
)
[55a38aaca11da398c854cb29a7d4f5e6] => Array
(
[schedule] =>
[args] => Array
(
[0] => 30272
)
)
[f8cbc904676c235c7057ec965c01c023] => Array
(
[schedule] =>
[args] => Array
(
[0] => 32390
)
)
)
)
)
Informe de la Agencia Europea del Medicamento (EMA) sobre las propuestas concretas para estimular el desarrollo de los fármacos de terapia avanzada. Este documento recopilatorio fue hecho público por parte del mencionado organismo regulatorio de ámbito comunitario el viernes, 2 de junio del año 2016.
Etiquetas: 3 de junio de 2016, Desarrollo, EMA, estimular, Fármacos, informe, Londres, Propuestas concretas, Sanidad, terapia avanzada.
La AEMPS ha publicado un documento de preguntas y respuestas sobre el RD 477/2014, por el que se regula la autorización de medicamentos de terapia avanzada de fabricación no industrial
Etiquetas: 22 septiembre 2014, 22/09/2014, AEMPS, Agencia española de medicamentos y productos sanitarios, Autorización, Documento, Documento de preguntas y respuestas, Ensayos clínicos, Fabricación del medicamento, fabricación no industrial, Farmacovigilancia, Good Manufacturing Practice, Informe Anual, Madrid, medicamentos, Medicamentos de terapia avanzada, Normas de correcta fabricación, Plasma Rico en Plaquetas, Preguntas, Producto, Producto en Investigación Clínica, PRP, RD 477/2014, Respuestas, salud, Sanidad, Situaciones excepcionales, terapia avanzada, Trazabilidad.
Utilizamos cookies propias y de terceros para recopilar información que ayuda a optimizar su visita. Las cookies no se utilizan para recoger información de carácter personal. Usted puede permitir su uso o rechazarlo, también puede cambiar su configuración siempre que lo desee. Al continuar con la navegación entendemos que se acepta nuestra política de cookies.
x